Last update 07 Jul 2026

LY-N001(Lingyi (Hangzhou) Biotechnology)

Overview

Basic Info

Drug Type
AAV based gene therapy
Synonyms
LY-N001
Target
GBA1
Action
modulators
Mechanism
GBA modulators(Beta-glucocerebrosidase modulators)
Therapeutic Areas
Nervous System DiseasesEndocrinology and Metabolic Disease
Active Indication
Parkinson Disease
Inactive Indication-
Originator Organization
Lingyi (Hangzhou) Biotechnology Co., Ltd.Lingyi (Hangzhou) Biotechnology Co., Ltd.
Active Organization
Lingyi (Hangzhou) Biotechnology Co., Ltd.Lingyi (Hangzhou) Biotechnology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with LY-N001(Lingyi (Hangzhou) Biotechnology)
NCT07685444
/ Not yet recruitingEarly Phase 1
A Prospective, Single-Arm, Single-Dose Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Intracerebral Administration of LY-N001 Injection in Subjects With Moderate to Advanced Parkinson's Disease Carrying GBA1 Mutations
100 Clinical Results associated with LY-N001(Lingyi (Hangzhou) Biotechnology)
Login to view more data
100 Translational Medicine associated with LY-N001(Lingyi (Hangzhou) Biotechnology)
Login to view more data
100 Patents (Medical) associated with LY-N001(Lingyi (Hangzhou) Biotechnology)
Login to view more data
100 Deals associated with LY-N001(Lingyi (Hangzhou) Biotechnology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Parkinson DiseasePhase 1
China
Lingyi (Hangzhou) Biotechnology Co., Ltd.Lingyi (Hangzhou) Biotechnology Co., Ltd.
07 Jul 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free